GinkgoSelect (Ginkgo biloba)

GinkgoSelect is a standardized extract of Ginkgo biloba delivering 24% flavone glycosides and 6% terpene lactones, including ginkgolides A, B, and C and bilobalide. These bioactives exert neuroprotective effects primarily through free radical scavenging, platelet-activating factor (PAF) inhibition, and modulation of cerebral blood flow.

Category: Other Evidence: 2/10 Tier: Preliminary (in-vitro/animal)
GinkgoSelect (Ginkgo biloba) — Hermetica Encyclopedia

Origin & History

GinkgoSelect is a branded standardized extract from the leaves of Ginkgo biloba L., a tree native to China and cultivated globally. It is produced by Indena using extraction methods involving aqueous acetone/water mixtures (70:30 ratio at 50-60°C) followed by liquid-liquid extraction with C4-C6 ketones, alkalinization, acidification, and final purification with aqueous ethanol.

Historical & Cultural Context

No historical or traditional medicine context for GinkgoSelect or Ginkgo biloba was detailed in the search results. Traditional Chinese Medicine uses and historical applications were not included in the available research.

Health Benefits

• Antioxidant support through free radical scavenging effects mediated by flavonoid and ginkgolide constituents (mechanism-based evidence only)
• Potential oxidative stress reduction via standardized flavonoids (44-78%) and ginkgolides (2.5-10%) (composition data only)
• May support cellular protection through terpenoid compounds including bilobalide (theoretical based on constituents)
• Possible cognitive support (no direct clinical evidence for GinkgoSelect provided)
• Potential circulatory benefits (no specific clinical data for this branded form)

How It Works

Ginkgo flavone glycosides, particularly quercetin and kaempferol glycosides, neutralize reactive oxygen species by donating hydrogen atoms to free radicals, reducing lipid peroxidation in neuronal membranes. Ginkgolides A and B act as selective antagonists of the platelet-activating factor (PAF) receptor, inhibiting platelet aggregation and supporting microcirculatory blood flow to the brain. Bilobalide has been shown to modulate GABA-A receptor activity and inhibit mitochondrial-derived apoptotic signaling, contributing to neuronal survival under oxidative stress conditions.

Scientific Research

No human clinical trials, RCTs, or meta-analyses specifically on GinkgoSelect were identified in the research. While general Ginkgo biloba extract evidence exists in broader literature (e.g., EGb 761), no PubMed PMIDs for GinkgoSelect-specific studies are available.

Clinical Summary

A Cochrane review analyzing over 36 randomized controlled trials with sample sizes ranging from 40 to 400 participants found modest but inconsistent evidence that standardized ginkgo extract (120–240 mg/day) improved cognitive symptoms in individuals with dementia or age-related cognitive decline. A landmark trial, the GEM Study (n=3,069), found no significant reduction in Alzheimer's disease incidence with 120 mg twice daily over 6 years compared to placebo. Smaller controlled trials (8–12 weeks) have reported statistically significant improvements in working memory and processing speed in healthy older adults, though effect sizes are generally small. Overall, evidence is considered moderate-quality for symptomatic cognitive support and insufficient to support disease prevention claims.

Nutritional Profile

GinkgoSelect (Ginkgo biloba) is a standardized botanical extract, not a conventional food ingredient, so macronutrient and micronutrient content is negligible at typical supplemental doses (40-120mg per serving). Key bioactive compounds include: Flavonoid glycosides (primarily quercetin, kaempferol, and isorhamnetin glycosides) standardized to 24% concentration in most commercial preparations, equating to approximately 9.6-28.8mg flavonoid glycosides per 40-120mg dose; Terpene lactones standardized to 6% total, comprising ginkgolides A, B, C (approximately 3.6-7.2mg per 40-120mg dose) and bilobalide (approximately 2.4-4.8mg per 40-120mg dose); Ginkgolide B specifically present at approximately 0.8-2.4mg per dose, considered the most pharmacologically active terpenoid. GinkgoSelect-branded extract specifies elevated flavonoid content (44-78%) and ginkgolide fractions (2.5-10%), indicating a more concentrated preparation than standard 24%/6% extracts, meaning flavonoid content may reach 17.6-93.6mg per 40-120mg dose depending on exact concentration used. Protein, fat, and carbohydrate content are negligible (<1mg each at supplemental doses). No meaningful vitamin or mineral content at these doses. Bioavailability: flavonoid glycosides are hydrolyzed in the gut to aglycone forms (quercetin, kaempferol) prior to absorption; oral bioavailability of ginkgolides estimated at 40-80%; bilobalide shows approximately 70% oral bioavailability based on pharmacokinetic studies. Ginkgolic acids (allergenic alkylphenols) are present at <5ppm in quality-controlled extracts per industry standards.

Preparation & Dosage

No clinically studied dosage ranges for GinkgoSelect are specified in the research. Standardized Ginkgo biloba extracts similar to GinkgoSelect typically contain 24% flavonoids and 6% terpenoids, with general dosing of 120-240 mg/day used in studies of comparable extracts. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Phosphatidylserine, Bacopa monnieri, Lion's Mane, Omega-3 fatty acids, Vitamin E

Safety & Interactions

GinkgoSelect is generally well tolerated at doses of 120–240 mg/day, with the most commonly reported adverse effects including mild headache, gastrointestinal upset, and dizziness. Due to PAF inhibition and antiplatelet activity, ginkgo carries a clinically meaningful interaction risk with anticoagulants such as warfarin and antiplatelet agents like aspirin or clopidogrel, potentially increasing bleeding time. It is contraindicated in individuals scheduled for surgery and should be discontinued at least 36–72 hours prior to procedures. Ginkgo is not recommended during pregnancy or breastfeeding due to insufficient safety data, and raw ginkgo seeds contain ginkgotoxin (4-O-methylpyridoxine), which is neurotoxic and absent in properly standardized extracts.